Executive Summary
This $3.98B batch of 14 high-value federal contracts (>$5M) signals strong bullish momentum for government contractors in IT modernization, construction, and remediation, with 11/14 rated bullish and total obligations skewed toward DOE ($1.7B Hanford cleanup) and HHS ($817M health exchange outreach).
Multi-year performance periods (avg. to 2026-2028) provide revenue visibility, but zero outlays in 6 contracts flag near-term cash flow delays. Institutional investors should prioritize public govcon equities like Oracle, Leidos, and Booz Allen for EHRM, border tech, and FBI IT exposure, while monitoring unexercised options totaling >$700M across deals.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior High-Value Federal Grants ($5M+) digest from March 11, 2026.
Investment Signals (4)
- DOE Hanford Cleanup Locked In at $1.7B (HIGH)▲
Central Plateau Cleanup's massive cost-plus incentive fee task order with $1.63B already outlayed underscores sustained federal remediation spending through 2024.
- Oracle Secures $245M VA EHRM Deployments (HIGH)▲
Twin non-competitive firm-fixed-price awards totaling $245M for EHRM Waves F/G through 2026 highlight Oracle's entrenched VA IT position despite zero outlays to date.
- DHS Border & Recruitment Surge ($263M Combined) (HIGH)▲
Leidos ($91M multi-energy portals), RQ-AECOM JV ($86M Coast Guard rebuild), and Marcom ($86M CBP marketing) reflect escalating DHS priorities in enforcement infrastructure and hiring.
- Govcon IT Wins via Open Competition (MEDIUM)▲
Booz Allen ($90M FBI EDAS), Miracle Systems ($224M CISA), and Rohde & Schwarz ($86M FAA VCS) demonstrate prime contractor strength in federal IT/program management.
Risk Flags (3)
- Execution [HIGH RISK]▼
Zero outlays in 6 contracts (43% of records, incl. $224M Miracle, $245M Oracle, $86M Marcom) delay revenue recognition amid long performance periods.
- Execution [MEDIUM RISK]▼
Firm-fixed-price structures in 5 contracts ($600M+ total, e.g., Leidos, BL Harbert) expose contractors to cost overruns without reimbursement.
- Market [MEDIUM RISK]▼
Extended periods to 2027-2033 (9/14 contracts) vulnerable to FY budget cuts or program shifts, especially T&M deals ($1.4B+).
Opportunities (3)
- ◆
Unexercised options exceed $700M (e.g., $51M IPG, $177M Booz Allen, $160M Rohde & Schwarz), plus extensions to 2030+ in Leidos/Booz Allen.
- ◆
Small/disadvantaged businesses winning open comp (Miracle $224M, Marcom $86M, Gama-1 $99M) signal set-aside spillover into unrestricted bids.
- ◆
Post-2024/2026 tailwinds in DOE cleanup, VA EHRM, FAA modernization position incumbents for recompetes.
Sector Themes (3)
- ◆
7/14 contracts ($900M+) target IT/EHRM/cloud (VA Oracle $245M, FBI Booz Allen $90M, FAA Rohde $86M, CISA Miracle $224M).
- ◆
4 contracts ($350M+) for border tech, Coast Guard rebuilds, CBP marketing amid enforcement priorities.
- ◆
DOE $1.7B Hanford + DOJ/FBI $183M dorms provide multi-year backlog in enviro/construction.
Watch List (3)
- 👁
{"entity"=>"Oracle Health Government Services", "reason"=>"$245M VA EHRM pipeline with non-compete edge and zero outlays signals outsized upside on deployment ramps.", "trigger"=>"First outlays or Wave expansions"}
- 👁
{"entity"=>"DHS Contractors (Leidos, RQ-AECOM, Marcom)", "reason"=>"$263M cluster in border/enforcement with long tails to 2033 exposes to policy volatility but high optionality.", "trigger"=>"FY2026 budget or option exercises"}
- 👁
{"entity"=>"Small Biz Outperformers (Miracle, Marcom, Gama-1)", "reason"=>"$410M wins despite open comp highlight certification alpha; private status limits liquidity but flags M&A.", "trigger"=>"Public peer outperformance or acquisitions"}
Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 14 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: High-Value Federal Grants ($5M+)
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals